Anterior ischemic optic neuropathy

Revision as of 05:02, 25 January 2009 by Zorkun (talk | contribs)
Jump to navigation Jump to search
Anterior ischemic optic neuropathy
ICD-9 377.41
OMIM 258660
DiseasesDB 31309
eMedicine oph/161 

WikiDoc Resources for Anterior ischemic optic neuropathy

Articles

Most recent articles on Anterior ischemic optic neuropathy

Most cited articles on Anterior ischemic optic neuropathy

Review articles on Anterior ischemic optic neuropathy

Articles on Anterior ischemic optic neuropathy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Anterior ischemic optic neuropathy

Images of Anterior ischemic optic neuropathy

Photos of Anterior ischemic optic neuropathy

Podcasts & MP3s on Anterior ischemic optic neuropathy

Videos on Anterior ischemic optic neuropathy

Evidence Based Medicine

Cochrane Collaboration on Anterior ischemic optic neuropathy

Bandolier on Anterior ischemic optic neuropathy

TRIP on Anterior ischemic optic neuropathy

Clinical Trials

Ongoing Trials on Anterior ischemic optic neuropathy at Clinical Trials.gov

Trial results on Anterior ischemic optic neuropathy

Clinical Trials on Anterior ischemic optic neuropathy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Anterior ischemic optic neuropathy

NICE Guidance on Anterior ischemic optic neuropathy

NHS PRODIGY Guidance

FDA on Anterior ischemic optic neuropathy

CDC on Anterior ischemic optic neuropathy

Books

Books on Anterior ischemic optic neuropathy

News

Anterior ischemic optic neuropathy in the news

Be alerted to news on Anterior ischemic optic neuropathy

News trends on Anterior ischemic optic neuropathy

Commentary

Blogs on Anterior ischemic optic neuropathy

Definitions

Definitions of Anterior ischemic optic neuropathy

Patient Resources / Community

Patient resources on Anterior ischemic optic neuropathy

Discussion groups on Anterior ischemic optic neuropathy

Patient Handouts on Anterior ischemic optic neuropathy

Directions to Hospitals Treating Anterior ischemic optic neuropathy

Risk calculators and risk factors for Anterior ischemic optic neuropathy

Healthcare Provider Resources

Symptoms of Anterior ischemic optic neuropathy

Causes & Risk Factors for Anterior ischemic optic neuropathy

Diagnostic studies for Anterior ischemic optic neuropathy

Treatment of Anterior ischemic optic neuropathy

Continuing Medical Education (CME)

CME Programs on Anterior ischemic optic neuropathy

International

Anterior ischemic optic neuropathy en Espanol

Anterior ischemic optic neuropathy en Francais

Business

Anterior ischemic optic neuropathy in the Marketplace

Patents on Anterior ischemic optic neuropathy

Experimental / Informatics

List of terms related to Anterior ischemic optic neuropathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Anterior ischemic optic neuropathy (AION) is a medical condition involving loss of vision due to damage to the optic nerve from insufficient blood supply. AION is generally divided into two types: arteritic AION (or AAION) and non-arteritic AION (NAION or simply AION). This article will focus primarily on non-arteritic AION.

The distinction between AAION and NAION was made to highlight the different etiologies of anterior ischemic optic neuropathy. AAION is due to temporal arteritis (also called giant cell arteritis), an inflammatory disease of medium-sized blood vessels that occurs especially with advancing age. In contrast, NAION results from the coincidence of cardiovascular risk factors in a patient with "crowded" optic discs. Non-arteritic AION is more common than AAION and usually occurs in a slightly younger group than AAION. While only a few cases of NAION result in near total loss of vision, most cases of AAION involve nearly complete vision loss.

Beyond this introduction, this article will focus on non-arteritic AION. For a discussion on arteritic AION see the separate article arteritic anterior ischemic optic neuropathy. Though the term "AION" can be used to describe either anterior ischemic optic neuropathy in general or non-arteritic AION specifically, in this article "AION" henceforth will be used to refer to non-arteritic anterior ischemic optic neuropathy.

Differential Diagnosis

  • Central Retinal Vein Occlusion
  • Ocular Hypotony
  • Papilledema
  • Pseudopapilledema

Symptoms and diagnosis

AION typically presents suddenly and upon awakening. The patient notes seeing poorly in one eye. Vision in that eye is obscured by a dark shadow, often involving just the upper or lower half of vision. There is no pain. There may be a slight improvement of visual acuity over the course of the next month, but generally, there is little change. There is a serious risk of a similar event occurring in the fellow eye over the next few years. Fortunately, it may not be terribly devastating as the visual acuity may remain only moderately impaired. Furthermore, most cases of AION involve the loss of a hemifield (either the upper or lower half of the visual field, but not both). A few cases of AION involve almost total loss of vision.

Since arteritic AION is similar in presentation to non-arteritic AION, patients over the age of 50 diagnosed with AION must be evaluated to exclude AAION (symptoms: painful jaw muscle spasms, scalp tenderness, unintentional weight loss, fatigue, myalgias and loss of appetite). Furthermore, AION patients over the age of 75 should often be blood tested regardless.

Incidence

It is estimated that the incidence of AION is about 8,000/year in the U.S.

Causes and risk factors

The mechanism of injury for AION used to be quite controversial. However, the experts in the field (neuro-ophthalmologists) have come to a consensus that most cases involve the convergence of two problems. The first is a predisposition in the form of a type of optic disc shape. The optic disc is the most anterior (forward) portion of the optic nerve, the bundle of nerves that carries the visual signals from the eye to the brain. This optic nerve must penetrate through the wall of the eye, and the hole to accommodate this is usually 20-30% larger than the nerve diameter. Hence there is extra space that acts as a margin of error. But some patients have no such margin. Their optic disc appears "crowded" when seen by ophthalmoscopy. Nonetheless, most patients with this optic disc shape see well all of their lives.

The second "hit" involves cardiovascular risk factors. The most common are diabetes, hypertension and high cholesterol levels. In patients with "a disc at risk", these vascular risk factors lead to ischemia (poor blood supply) to a portion of the optic disc. The disc then swells, but the crowded conditions don't allow space for this, so compression occurs and this leads to more ischemia. Since both eyes tend to have a similar shape, the ophthalmologist will look at the good eye to assess the anatomical predisposition.

There is evidence that genetic factors may play a role in NAION. (see the OMIM link)

A number of studies have linked Viagra use with NAION.[1][2][3][4][5][6]

Treatment

Once AION happens, there is no accepted treatment to reverse the damage, but prevention of further damage may be possible. Common sense dictates trying to control the cardiovascular risk factors for many reasons, including protection from this happening to the second eye. Sudden vision loss should lead to an ophthalmological consultation. If AION is suspected, then ideally a neuro-ophthalmology consultation should be obtained. Some rare causes of AION are treatable.

There is much research currently underway looking at ways to protect the nerve (neuroprotection) or even regenerate new fibers within the optic nerve. There are no current clinical trials for the treatment of AION.

References

  1. Pomeranz HD, Bhavsar AR. "Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (viagra): a report of seven new cases." J Neuroophthalmol. 2005 Mar;25(1):9-13. PMID 15756125.
  2. Egan R, Pomeranz H. "Sildenafil (Viagra) associated anterior ischemic optic neuropathy." Arch Ophthalmol. 2000 Feb;118(2):291-2. PMID 10676804.
  3. Pomeranz HD, Smith KH, Hart WM Jr, Egan RA. "Sildenafil-associated nonarteritic anterior ischemic optic neuropathy." Ophthalmology. 2002 Mar;109(3):584-7. PMID 11874765.
  4. Cunningham AV, Smith KH. "Anterior ischemic optic neuropathy associated with viagra." J Neuroophthalmol. 2001 Mar;21(1):22-5. PMID 11315976.
  5. Boshier A, Pambakian N, Shakir SA. "A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil." Int J Clin Pharmacol Ther. 2002 Sep;40(9):422-3. PMID 12358159.
  6. Akash R, Hrishikesh D, Amith P, Sabah S. "Case report: association of combined nonarteritic anterior ischemic optic neuropathy (NAION) and obstruction of cilioretinal artery with overdose of Viagra." J Ocul Pharmacol Ther. 2005 Aug;21(4):315-7. PMID 16117695.

External links

Template:SIB

de:Anteriore ischämische Optikusneuropathie


Template:WS